A new issue of the online weekly of The Scripps Research Institute, News&Views, is now available at http://www.scripps.edu/newsandviews
TSRI Chemists Modify Antibiotic to Vanquish Resistant Bacteria
The Boger lab has made a powerful analog of vancomycin that is effective against MRSA and other disease-causing bacteria.
Toward a New Drug for Multiple Sclerosis
On the occasion of positive new data for RPC1063, Professor Hugh Rosen shares his perspective on the drug candidate, which was initially discovered, synthesized and developed at TSRI.
Jack Johnson Honored as Outstanding Mentor
Professor Jack Johnson was nominated with 22 letters of support from current and former trainees.
New Genomic Equipment at TSRI Enables Scientists to Analyze Single Cells
“It has added power to many of the technologies we already have on campus," says Professor Luc Teyton.
To unsubscribe from this mailing list, reply to this email with the word UNSUBSCRIBE in the Subject line.